Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 3.680
-0.010 (-0.27%)
Apr 29, 2026, 3:00 PM CST
SHA:600664 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 346.98 | 398.78 | 628.85 | 395.26 | 465.15 | 371.08 |
Depreciation & Amortization | 275.24 | 275.24 | 263.76 | 304.2 | 310.39 | 307.54 |
Other Amortization | 4.95 | 4.95 | 29.14 | 21.88 | 10.97 | 19.61 |
Loss (Gain) From Sale of Assets | -3.83 | -3.83 | -1.03 | -1.33 | -161.38 | -210.74 |
Asset Writedown & Restructuring Costs | 31.25 | 31.25 | 59.94 | 1.16 | 33.59 | 2.19 |
Loss (Gain) From Sale of Investments | -0.31 | -0.31 | -12.44 | -4.48 | -20.33 | -0.85 |
Provision & Write-off of Bad Debts | - | - | 35.92 | 26.22 | -1.67 | 10.94 |
Other Operating Activities | 449.93 | 119.62 | 90.07 | 172.59 | 150.13 | 144.79 |
Change in Accounts Receivable | 224.21 | 224.21 | 118.67 | -94.42 | -237.95 | -613.94 |
Change in Inventory | -198.19 | -198.19 | 36.7 | -119.59 | 277.86 | -166.46 |
Change in Accounts Payable | -410.14 | -410.14 | -450.37 | 245.21 | -202.97 | -30.11 |
Change in Other Net Operating Assets | -0.04 | -0.04 | -0.38 | - | - | - |
Operating Cash Flow | 718.17 | 439.66 | 792.5 | 949.67 | 622.09 | -162.44 |
Operating Cash Flow Growth | 19.95% | -44.52% | -16.55% | 52.66% | - | - |
Capital Expenditures | -152.22 | -150.95 | -100.81 | -86.54 | -89.65 | -76.7 |
Sale of Property, Plant & Equipment | 5.26 | 7.57 | 1.2 | 35.94 | 151.03 | 177.46 |
Cash Acquisitions | - | - | -0.01 | - | - | - |
Divestitures | - | - | - | -156.64 | - | - |
Other Investing Activities | 0.29 | 0.29 | 0.71 | 0.59 | 10.95 | -9.15 |
Investing Cash Flow | -146.67 | -143.09 | -98.91 | -206.64 | 72.34 | 91.62 |
Long-Term Debt Issued | - | 1,347 | 1,905 | 3,207 | 2,158 | 1,857 |
Long-Term Debt Repaid | - | -1,699 | -1,958 | -3,435 | -2,076 | -1,220 |
Net Debt Issued (Repaid) | -121.06 | -352.23 | -53.49 | -228.23 | 82.06 | 637.06 |
Issuance of Common Stock | - | - | - | 3.73 | 16.98 | 15.53 |
Repurchase of Common Stock | - | - | -3.98 | -8.36 | - | - |
Common Dividends Paid | -25.31 | -33.29 | -47.11 | -44.16 | -54.3 | -61.55 |
Other Financing Activities | -64.24 | -71.67 | -21.02 | 424.97 | 129.88 | -197.78 |
Financing Cash Flow | -210.61 | -457.19 | -125.61 | 147.94 | 174.62 | 393.26 |
Foreign Exchange Rate Adjustments | -3.97 | -2.69 | 2.24 | 0.92 | 3.74 | -2.91 |
Net Cash Flow | 356.92 | -163.31 | 570.22 | 891.89 | 872.79 | 319.54 |
Free Cash Flow | 565.95 | 288.71 | 691.69 | 863.14 | 532.45 | -239.13 |
Free Cash Flow Growth | 14.85% | -58.26% | -19.86% | 62.11% | - | - |
Free Cash Flow Margin | 3.55% | 1.81% | 4.28% | 5.58% | 3.86% | -1.87% |
Free Cash Flow Per Share | 0.22 | 0.11 | 0.28 | 0.35 | 0.21 | -0.10 |
Cash Income Tax Paid | 711.4 | 732.3 | 810.92 | 815.72 | 728.98 | 711.43 |
Levered Free Cash Flow | 761.56 | 545.23 | 636.83 | 898.47 | 837.21 | 310.96 |
Unlevered Free Cash Flow | 761.56 | 545.23 | 674.37 | 933.76 | 890.67 | 376.68 |
Change in Working Capital | -386.05 | -386.05 | -301.7 | 34.17 | -164.76 | -807.01 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.